Lena Jendeberg

Lena Jendeberg is an experienced professional in project management and leadership within the pharmaceutical and biotechnology sectors. Currently serving as the Director of Project Management at Alexion Pharmaceuticals, Inc. since February 2019, Lena also holds a position as a Board Member at Attana AB since May 2018. Prior to these roles, Lena was the Head of Project Management at Wilson Therapeutics for one year and served as the VP of Development at Modus Therapeutics AB from February 2016 to January 2018. Lena's extensive career at Biovitrum from 2001 to February 2016 included roles as a Program Director in Inflammation and Project Lead. Educational qualifications include a longstanding affiliation with KTH Royal Institute of Technology.